Mode VC
Peter Wung, MD, MHS

Peter Wung, MD, MHS

Venture Partner atForesite CapitalCalifornia
Full bioFirm profile

Peter Wung is a Venture Partner at Foresite Capital and leads clinical strategy at Foresite Labs. He has 15 years of pharmaceutical industry experience, including roles at Candid Therapeutics, Kyverna Therapeutics, AbbVie, and Sanofi.

What Peter can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Parexel · global medical lead for Taltz (ixekizumab)
  2. Sanofi · Head of Clinical Development Operations of Immunology & Inflammation
  3. AbbVie · Global Development Lead for Rinvoq (upadacitinib)
  4. Kyverna Therapeutics · Head of Clinical Development and Operations
  5. Candid Therapeutics · SVP Head of Clinical Development
  6. Foresite Labs · leads clinical and development strategy
  7. Foresite Capital · Venture Partner
    Now

Focus

immunologyrheumatologydermatologyneurologypulmonology

Education

Case Western Reserve University, B.S. in Computer ScienceJohns Hopkins Bloomberg School of Public Health, M.H.S. in Clinical InvestigationsThe Ohio State University College of Medicine, M.D.Johns Hopkins, internal medicine residency and rheumatology fellowship

Also at Foresite Capital

Hyung Chun, MD
Hyung Chun, MDPartner
Shannon Bergstedt
Shannon BergstedtPartner
Collin Yang-Wong
Collin Yang-WongPrincipal
Deepak Atri, MD
Deepak Atri, MDPrincipal
Vishal Deshmukh, PhD
Vishal Deshmukh, PhDPrincipal
Insiya Essani
Insiya EssaniSenior Associate
Jorge Reis-Filho, MD, PhD, FRCPath
Jorge Reis-Filho, MD, PhD, FRCPathVenture Partner
Liang Chang, PhD
Liang Chang, PhDVenture Partner

Partners like Peter

At firms with a similar stage, sector and check size.

Rick Moss
Rick MossFounding Partner, Better Ventures
Peter LeeGeneral Partner, Embark Ventures
David FleckFounder & Managing Partner, Freeflow Ventures
Michael Liao
Michael LiaoManaging Director, Heuristic Capital
Ibrahim Ajami
Ibrahim AjamiSenior Partner, Head of Ventures, Mubadala Capital Ventures
Po BronsonGeneral Partner & Managing Director, SOSV SF, SOSV SF & NY (Fka IndieBio)

Alert me when Foresite Capital is active

One email when Peter's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Peter Wung, MD, MHS?

Peter Wung is a Venture Partner at Foresite Capital and leads clinical strategy at Foresite Labs. He has 15 years of pharmaceutical industry experience, including roles at Candid Therapeutics, Kyverna Therapeutics, AbbVie, and Sanofi.

How much does Peter Wung, MD, MHS invest?

Foresite Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Peter Wung, MD, MHS?

A warm intro from a founder Foresite Capital backed works best.

What did Peter Wung, MD, MHS do before Foresite Capital?

global medical lead for Taltz (ixekizumab) at Parexel; Head of Clinical Development Operations of Immunology & Inflammation at Sanofi; Global Development Lead for Rinvoq (upadacitinib) at AbbVie; Head of Clinical Development and Operations at Kyverna Therapeutics; SVP Head of Clinical Development at Candid Therapeutics; leads clinical and development strategy at Foresite Labs.

Last updated 2026-10-15. Is this you? Ask for a correction.